Takaaki Ono

9PUBLICATIONS
42CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 14, 2026
ELTS Score and Early "Warning" Define a Two-Stage Risk Framework for Failure-Free Survival in Chronic-Phase CML.

|Jun 18, 2026
Treatment-Free Remission and Immune Profiling after Frontline Second-Generation TKI Therapy in CML.

|Jun 11, 2026
Early predictors of MR4.5 attainment and eligibility for TKI discontinuation in CML treated with second-generation TKIs.

|Jul 05, 2024
Nilotinib vs dasatinib in achieving MR4.5 for de novo chronic myeloid leukemia: the randomized JALSG CML212 study.

Itaru Matsumura, Shigeki Ohtake, Yoshiko Atsuta

|Feb 16, 2023
Clinical utility of genomic profiling of AML using paraffin-embedded bone marrow clots: HM-SCREEN-Japan 01.

Naoko Hosono, SungGi Chi, Takahiro Yamauchi

|Nov 07, 2022
Clinical outcomes of second-generation tyrosine kinase inhibitors versus imatinib in older patients with CML.

Takaaki Ono, Naoto Takahashi, Masahiro Kizaki

Pageof 2

Frequent Collaborators

7 joint publications

Naoto Takahashi

6 joint publications

Itaru Matsumura

5 joint publications

Yosuke Minami

4 joint publications

Kazuhito Yamamoto